Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Tight liquidity NBB
Cash and receivables cover 19 % of short-term debt in 2025; threshold 65 %.
Financials
Financial year 2025
Bobbie Pharmaceutical Services from Wingene, company number BE0799344237, closed financial year 2025 with a result of € -1.2 million after tax. For that financial year Bobbie Pharmaceutical Services recorded revenue of € 1.5 million and equity of € 17.5 million. Compared with financial year 2024, the result moved from € 1.6 million to € -1.2 million. The company made a loss. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 3, 2026.
€ 17.5 million
▲ 79% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -1.2 million
▼ still € 1.6 million profit in 2024
Profit after tax over the fiscal year.
€ 79,683
▼ 4% vs 2024
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € 3.7 million.
Debts at end 2025
€ 24.6 million
▲ 9% vs 2024
€ 1.3 million is repaid this year. At this pace the long-term loan is gone in ≈ 16 years.
€ 642,835
▲ € 563,063 vs 2024
Supplier invoices still open on the last day of the fiscal year. Pays suppliers within 149 days on average.
€ 227,136
▼ 37% vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2024 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|
| Revenue | - | € 1,954,000 | € 1,528,333 | ▼ 22% |
| Gross margin | € 1,008,714 | - | - | |
| Profit after taxes | € 2,903,648 | € 1,612,642 | € -1,151,746 | ▼ € 2.8 million |
| Equity | € 8,153,648 | € 9,766,290 | € 17,506,021 | ▲ 79% |
| Total debts | € 25,933,609 | € 23,563,800 | € 29,458,513 | ▲ 25% |
| Cash | € 10,026 | € 83,255 | € 79,683 | ▼ 4% |
| Retained profit | € 2,903,648 | € 4,516,290 | € 3,711,123 | ▼ 18% |
| Bank debt | € 24,170,000 | € 22,595,714 | € 24,574,121 | ▲ 9% |
| Balance sheet total | € 34,087,257 | € 33,330,090 | € 46,964,534 | ▲ 41% |
Key figures of Bobbie Pharmaceutical Services, fiscal years 2024 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to Bobbie Pharmaceutical Services?
What happened at Bobbie Pharmaceutical Services in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: loss of € 1.2 million (▼ € 2.8 million vs 2024). Source: NBB ↗
- Philip Van Damme BV became a director. NBB
- Meulemeester Steven BV became a director. NBB
- Pure Management BV became a director. NBB
- Vybros Capital Partners BV became a director. NBB
- Meulemeester Didrik BV became a director. NBB
- New establishment in Wingene. KBO
- CéVéGé BV became a director. NBB
In short
From € 2.9 million profit in 2024 to € 1.2 million loss in 2025.
Paid € 227,136 in corporate taxes since 2024.
Best year ever: 2024, with € 2.9 million profit.
Pays suppliers within 149 days on average.
A new publication or filing at Bobbie Pharmaceutical Services? We notify you, reason included.
Follow Bobbie Pharmaceutical ServicesDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
The stake of Vybros Capital Partners comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
Bobbie Pharmaceutical ServicesBehind Bobbie Pharmaceutical Services are Philip Van Damme BV, Meulemeester Steven BV, Pure Management BV, Vybros Capital Partners BV, Meulemeester Didrik BV and CéVéGé BV. The shares are held by Vybros Capital Partners (40.1%). It owns 100% of Medipack Immo, 100% of Farmadistri, 100% of Farmazorg, 100% of Vergel and 100% of Ultimedi itself.
Directors
According to the 2025 annual accounts
Director · represented by Philip Van Damme
Also active at: APOTHEEK VAN DAMME, Farmadistri, FARMAZORG
since 2025
Director · represented by Steven Meulemeester
Also active at: STEDIPHAR, Farmadistri, FARMAZORG, DISTEPHAR, MEDIPACK
since 2025
Director · represented by Phillipe De Dijcker
Also active at: Farmadistri, FARMAZORG, MEDIPACK
since 2025
Director · represented by Stijn Nauts
Also active at: LUDO, JAGA, VERMA ENGINEERING, ALLE BOUW MACHINES, VYTECH MENEN, VYTECH DUFFEL, IMMAN L4, INTERMAT +24 more
since 2025
Director · represented by Didrik Meulemeester
Also active at: STEDIPHAR, Farmadistri, FARMAZORG, DISTEPHAR
since 2025
since 2023
Managing director · represented by Benoit Devroe
since 2023
Shareholders
40.1%
Participations
Establishments
Establishment units
Physical locations of this company
Flandria 3
8750 Wingene
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 3 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0799.344.237
- VAT number
- BE 0799.344.237
- Registered office
- Flandria 3, 8750 Wingene
- Names & denominations
- Bobbie Pharmaceutical Services · BOPHAS
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 9 March 2023
- Peppol
- Active · Active since 29 Apr 2026
- Activities · NACE
Activiteiten van holdings
Holdings
Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies
Activiteiten van hoofdkantoren
Overige zakelijke dienstverlening, neg
Activiteiten op het gebied van computerconsultancy en beheer van computerfaciliteiten
Overige adviesbureaus op het gebied van bedrijfsbeheer; adviesbureaus op het gebied van bedrijfsvoering
Computerconsultancy-activiteiten